Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | 75,000 | reported | 01 Jul 2025 | tx 7+425,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jul 2025 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 01 Jul 2023 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 28 Mar 2022 | PURCHASE | Lineage Cell Therapeutics, Inc. | 35,000 | 1.63 USD | |
| 01 Jul 2021 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 20 Apr 2021 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |